Company subsidiary hVIVO will conduct study with a US biotech
Around 400,000 people in the UK are living with rheumatoid arthritis
PARP inhibitor approved for new ovarian and prostate cancer indications
An enzyme that helps COVID-19 (coronavirus) infect the body also plays a role in inflammation and patient outcomes […]
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
Updated Date: Thu, 29 Oct 2020 00:00:00 EDT
